LINDSAY SPEER: Open Payments
NPI 1447584743 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 60 payments from 19 companies in 2025. Trend: 2023 $925 · 2024 $700 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $232 |
| PFIZER INC. | 14 | $183 |
| Novo Nordisk Inc | 7 | $105 |
| Lilly USA, LLC | 4 | $81 |
| Viatris Specialty LLC | 2 | $52 |
| Amgen Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Radius Health, Inc. | 1 | $31 |
Products named: QULIPTA, ELIQUIS, MOUNJARO, VRAYLAR, Ozempic, YUPELRI, PREVNAR 20, EVENITY.
Industry payments across SD — which companies pay providers there.
